Boosting the Economy and Driving Innovation
Between 1998 and 2018, NCI SBIR/STTR awardees fueled $26.1 billion in economic output, 100,000+ jobs, and breakthrough cancer technologies.
Learn MoreAdditional NCI Funding Opportunities
While the NCI SBIR program awaits reauthorization, please consider additional NCI funding opportunities for cancer technology development.
Explore Opportunities
Success Story: Illumina
Biomedical researchers at Illumina are developing next-generation tools to analyze genetic variation and function on a massive scale. Illumina used NCI SBIR funding to develop their next generation sequencing technology.
Learn More
Why SBIR?